Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Noninfectious uveitis | |||
| Infectious uveitis |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 12 months post-treatment |
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 12 months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Best corrected visual acuity | Best corrected visual acuity | 1 month post-treatment |
| Best corrected visual acuity | Best corrected visual acuity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study population are adult uveitis patients.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ye Dai, doctor | Contact | 13512721192 | daiye@gzzoc.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zhongshan Ophthalmic Center | Recruiting | Guangzhou | Guangdong | China |
Not provided
| ID | Term |
|---|---|
| D014605 | Uveitis |
| ID | Term |
|---|---|
| D014603 | Uveal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months post-treatment |
| Best corrected visual acuity | Best corrected visual acuity | 6 months post-treatment |
| Best corrected visual acuity | Best corrected visual acuity | 12 months post-treatment |
| Best corrected visual acuity | Best corrected visual acuity | 24 months post-treatment |
| Best corrected visual acuity | Best corrected visual acuity | 36 months post-treatment |
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 1 month post-treatment |
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 3 months post-treatment |
| The number of intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 6 months post-treatment |
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 12 months post-treatment |
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 24 months post-treatment |
| The number of Intraocular pressure | The number of Intraocular pressure was examed by non-contact tonometer | 36 months post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 1 month post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 3 months post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 6 months post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 12 months post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 24 months post-treatment |
| Central retinal thickness | Central retinal thickness was evaluated by Optical Coherence Tomography | 36 months post-treatment |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 1 month post-treatment |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 3 months post-treatment |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 6 months post-treatment |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 24 months post-treatment |
| The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system | 36 months post-treatment |
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 3 months post-treatment |
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 6 months post-treatment |
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 24 months post-treatment |
| The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions | inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography | 36 months post-treatment |